Hexima Ltd (HXL) - Total Liabilities

Latest as of June 2025: AU$40.70K AUD ≈ $28.80K USD

Based on the latest financial reports, Hexima Ltd (HXL) has total liabilities worth AU$40.70K AUD (≈ $28.80K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Hexima Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Hexima Ltd - Total Liabilities Trend (2005–2024)

This chart illustrates how Hexima Ltd's total liabilities have evolved over time, based on quarterly financial data. See HXL FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Hexima Ltd Competitors by Total Liabilities

The table below lists competitors of Hexima Ltd ranked by their total liabilities.

Company Country Total Liabilities
Literacy Capital PLC
LSE:BOOK
UK GBX29.03 Million
Moleculin Biotech Inc
NASDAQ:MBRX
USA $7.12 Million
Cynata Therapeutics Ltd
AU:CYP
Australia AU$1.22 Million
Kiplin Metals Inc
V:KIP
Canada CA$24.99K
Cascadero Copper Corp
V:CCD
Canada CA$863.86K
Grosvenor Resource Corp
V:GVR
Canada CA$27.50K
Kneomedia Ltd
AU:KNM
Australia AU$4.03 Million
Techindia Nirman Limited
NSE:TECHIN
India Rs709.43 Million

Liability Composition Analysis (2005–2024)

This chart breaks down Hexima Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see HXL market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 38.26 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 37.73 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.03 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.03 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hexima Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hexima Ltd (2005–2024)

The table below shows the annual total liabilities of Hexima Ltd from 2005 to 2024.

Year Total Liabilities Change
2024-12-31 AU$40.70K
≈ $28.80K
-83.63%
2023-12-31 AU$248.67K
≈ $175.95K
+42.55%
2022-12-31 AU$174.45K
≈ $123.43K
-97.18%
2021-12-31 AU$6.19 Million
≈ $4.38 Million
+11.90%
2020-12-31 AU$5.53 Million
≈ $3.91 Million
+63.16%
2019-12-31 AU$3.39 Million
≈ $2.40 Million
-13.82%
2018-12-31 AU$3.93 Million
≈ $2.78 Million
+94.59%
2017-12-31 AU$2.02 Million
≈ $1.43 Million
+8.12%
2016-12-31 AU$1.87 Million
≈ $1.32 Million
-7.14%
2015-12-31 AU$2.01 Million
≈ $1.42 Million
+10.66%
2014-12-31 AU$1.82 Million
≈ $1.29 Million
-8.10%
2013-12-31 AU$1.98 Million
≈ $1.40 Million
+30.82%
2012-12-31 AU$1.51 Million
≈ $1.07 Million
-42.49%
2009-12-31 AU$2.63 Million
≈ $1.86 Million
+1.95%
2008-12-31 AU$2.58 Million
≈ $1.83 Million
-11.50%
2007-12-31 AU$2.92 Million
≈ $2.06 Million
-80.75%
2006-12-31 AU$15.15 Million
≈ $10.72 Million
+335.74%
2005-12-31 AU$3.48 Million
≈ $2.46 Million
--

About Hexima Ltd

AU:HXL Australia Shell Companies
Market Cap
$6.15 Million
AU$8.69 Million AUD
Market Cap Rank
#29895 Global
#1741 in Australia
Share Price
AU$0.05
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.05
All Time High
AU$0.50
About

Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company's assets. Previously, the company was involved in the research and development of plant-derived proteins for applications as human therapeutics. Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia.